Covance Antibody Services' Unit Acquisition

Covance Antibody Services raised a round of funding on September 02, 2014. Investors include BioLegend.

Covance Antibody Services develops and manufactures antibodies and research reagents for Neuroscience, Immunopathology, Cell Biology, Epitope Tags, and Immunohistochemistry Detection.…

Articles about Covance Antibody Services' Unit Acquisition: